Details of the Drug Reposition

General Information of This Drug (ID: DMSZQAK)

Drug Name
Amphetamine   DMSZQAK
Synonyms Amphetamine (tamper and abuse-resistant, Bio-MD/MPAR, ADHD); Amphetamine (tamper and abuse-resistant, Bio-MD/MPAR, ADHD), PharmacoFore; PF-08 (Bio-MD/MPAR/prodrug/oral, ADHD), PharmacoFore
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Obesity DIS47Y1K 5B81 Approved [1]
Attention deficit hyperactivity disorder DISL8MX9 6A05.Z Approved [2]
Depression DIS3XJ69 6A70-6A7Z Approved [1]
Narcolepsy DISLCNLI 7A20 Approved [1]
------------------------------------------------------------------------------------
1 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Neurotoxicity DISQ7PDT NE61 Discontinued in Phase 2 [3]
------------------------------------------------------------------------------------

References

1 Amphetamine FDA Label
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3 Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial Meningioma